Alkem Laboratories intimates of successful USFDA inspection of facility in St Louis
Zero observations issued under Form 483
Alkem Laboratories announced that US FDA had conducted an inspection at the Company's manufacturing facility located at St Louis, USA from 23 October, 2017 to 27 October, 2017. At the end of the inspection, no Form 483 was issued.Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content